Answer
The median terminal half-life of infliximab after a single intravenous dose of 3, 5 or 10 mg/kg ranges from 8 to 9.5 days.
Sources for this answer
- Remicade 100mg powder for concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §5.2 Pharmacokinetic properties · Version 75Document updated
Sources checked